Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice

Infection and Immunity

Volumn 77, Issue 11, 2009, Pages 5181-5189

  Magnani, D M ^a   Harms, J S ^a   Durward, M A ^a   Splitter, G A ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUCELLA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; GENETIC TRANSCRIPTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; CYTOTOXICITY, IMMUNOLOGIC; GAMMA RAYS; MICE; VACCINES, ATTENUATED; VIRULENCE FACTORS;

EID: 70350451436     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00231-09     Document Type: Article

References (48)

1. Al Dahouk, S., V. Jubier-Maurin, H. C. Scholz, H. Tomaso, W. Karges, H. Neubauer, and S. Kohler. 2008. Quantitative analysis of the intramacrophagic Brucella suis proteome reveals metabolic adaptation to late stage of cellular infection. Proteomics 8:3862-3870.
2. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337. (Pubitemid 20010164)
3. Arenas, G. N., A. S. Staskevich, A. Aballay, and L. S. Mayorga. 2000. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect. Immun. 68:4255-4263.
4. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
5. Billard, E., C. Cazevieille, J. Dornand, and A. Gross. 2005. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun. 73:8418-8424. (Pubitemid 41740335)
6. Blasco, J. M. 1997. A review of the use of B. melitensis Rev-1 vaccine in adult sheep and goats. Prev. Vet. Med. 31:275-283.
7. Boschiroli, M. L., S. Ouahrani-Bettache, V. Foulongne, S. Michaux-Charachon, G. Bourg, A. Allardet-Servent, C. Cazevieille, J. P. Liautard, M. Ramuz, and D. O'Callaghan. 2002. The Brucella suis virB operon is induced intracellularly in macrophages. Proc. Natl. Acad. Sci. USA 99:1544-1549.
8. Brockstedt, D. G., K. S. Bahjat, M. A. Giedlin, W. Liu, M. Leong, W. Luckett, Y. Gao, P. Schnupf, D. Kapadia, G. Castro, J. Y. Lim, A. Sampson-Johannes, A. A. Herskovits, A. Stassinopoulos, H. G. Bouwer, J. E. Hearst, D. A. Portnoy, D. N. Cook, and T. W. Dubensky, Jr. 2005. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat. Med. 11:853-860.
9. Celli, J., C. de Chastellier, D. M. Franchini, J. Pizarro-Cerda, E. Moreno, and J. P. Gorvel. 2003. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:545-556.
10. Celli, J., and J. P. Gorvel. 2004. Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr. Opin. Microbiol. 7:93-97.
11. Chen, C. Y., G. W. Nace, and P. L. Irwin. 2003. A 6×6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J. Microbiol. Methods 55:475-479.
12. Comerci, D. J., M. J. Martinez-Lorenzo, R. Sieira, J. P. Gorvel, and R. A. Ugalde. 2001. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell Microbiol. 3:159-168.
13. Datta, S. K., S. Okamoto, T. Hayashi, S. S. Shin, I. Mihajlov, A. Fermin, D. G. Guiney, J. Fierer, and E. Raz. 2006. Vaccination with irradiated Listeria induces protective T-cell immunity. Immunity 25:143-152.
14. de Jong, M. F., Y. H. Sun, A. B. den Hartigh, J. M. van Dijl, and R. M. Tsolis. 2008. Identification of VceA and VceC, two members of the VjbR regulon that are translocated into macrophages by the Brucella type IV secretion system. Mol. Microbiol. 6:1378-1396.
15. den Hartigh, A. B., H. G. Rolan, M. F. de Jong, and R. M. Tsolis. 2008. VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system. J. Bacteriol. 190: 4427-4436.
16. Doyle, T. C., S. M. Burns, and C. H. Contag. 2004. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol. 6:303-317.
17. Franco, M. P., M. Mulder, R. H. Gilman, and H. L. Smits. 2007. Human brucellosis. Lancet Infect. Dis. 7:775-786.
18. Gonzalez, D., M. J. Grillo, M. J. De Miguel, T. Ali, V. Arce-Gorvel, R. M. Delrue, R. Conde-Alvarez, P. Munoz, I. Lopez-Goni, M. Iriarte, C. M. Marin, A. Weintraub, G. Widmalm, M. Zygmunt, J. J. Letesson, J. P. Gorvel, J. M. Blasco, and I. Moriyon. 2008. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS ONE 3:e2760.
19. Hiramoto, R. M., A. J. Galisteo, N. do Nascimento, and H. F. de Andrade. 2002. 200 Gy sterilized Toxoplasma gondii tachyzoites maintain metabolic functions and mammalian cell invasion, eliciting cellular immunity and cytokine response similar to natural infection in mice. Vaccine 20:2072-2081.
20. Hunter, P., S. M. Pefanis, C. C. Williamson, W. J. Botha, and M. S. Van Schalkwyk. 1989. Horizontal transmission in sheep and delayed clearance in guinea pigs and mice of a Brucella melitensis Rev. I mutant. J. South Afr. Vet. Assoc. 60:92-94.
21. Kaufmann, S. H. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129-163.
22. Ko, J., A. Gendron-Fitzpatrick, T. A. Ficht, and G. A. Splitter. 2002. Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice. Infect. Immun. 70:7004-7012.
23. Li, Z., X. Zhao, D. E. Higgins, and F. R. Frankel. 2005. Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity. Infect. Immun. 73:5065-5073.
24. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kündig, R. Amakawa, K. Kishihara, A. Wakeham, J. Potter, C. L. Furlonger, A. Narendran, H. Suzuki, P. S. Ohashi, C. J. Paige, T. Taniguchi, and T. W. Mak. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83-97. (Pubitemid 23306023)
25. Meighen, E. A. 1991. Molecular biology of bacterial bioluminescence. Microbiol. Rev. 55:123-142.
26. Montaraz, J. A., and A. J. Winter. 1986. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect. Immun. 53:245-251.
27. Nicoletti, P. 1990. Vaccination against Brucella. Adv. Biotechnol. Processes 13:147-168.
28. lo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25:2551-2557.
29. Pappagianis, D., S. S. Elberg, and D. Crouch. 1966. Immunization against Brucella infections: effects of graded doses of viable attenuated Brucella melitensis in humans. Am. J. Epidemiol. 84:21-31.
30. Pappas, G., N. Akritidis, M. Bosilkovski, and E. Tsianos. 2005. Brucellosis. N. Engl. J. Med. 352:2325-2336.
31. Pappas, G., P. Papadimitriou, N. Akritidis, L. Christou, and E. V. Tsianos. 2006. The new global map of human brucellosis. Lancet Infect. Dis. 6:91-99.
32. Rajashekara, G., D. A. Glover, M. Banai, D. O'Callaghan, and G. A. Splitter. 2006. Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice. Infect. Immun. 74:2925-2936.
33. Rajashekara, G., D. A. Glover, M. Krepps, and G. A. Splitter. 2005. Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell Microbiol. 7:1459-1473.
34. Rajashekara, G., M. Krepps, L. Eskra, A. Mathison, A. Montgomery, Y. Ishii, and G. Splitter. 2005. Unraveling Brucella genomics and pathogenesis in immunocompromised IRF-1 mice. Am. J. Reprod. Immunol. 54:358-368.
35. Rambow-Larsen, A. A., G. Rajashekara, E. Petersen, and G. Splitter. 2008. Putative quorum-sensing regulator BlxR of Brucella melitensis regulates virulence factors including the type IV secretion system and flagella. J. Bacteriol. 190:3274-3282.
36. Rolan, H. G., and R. M. Tsolis. 2008. Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection. Infect. Immun. 76:3207-3213.
37. Roux, C. M., H. G. Rolan, R. L. Santos, P. D. Beremand, T. L. Thomas, L. G. Adams, and R. M. Tsolis. 2007. Brucella requires a functional type IV secretion system to elicit innate immune responses in mice. Cell Microbiol. 9:1851-1869.
38. Salcedo, S. P., M. I. Marchesini, H. Lelouard, E. Fugier, G. Jolly, S. Balor, A. Muller, N. Lapaque, O. Demaria, L. Alexopoulou, D. J. Comerci, R. A. Ugalde, P. Pierre, and J. P. Gorvel. 2008. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog. 4:e21.
39. Sanakkayala, N., A. Sokolovska, J. Gulani, H. Hogenesch, N. Sriranganathan, S. M. Boyle, G. G. Schurig, and R. Vemulapalli. 2005. Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51. Clin. Diagn. Lab. Immunol. 12:1429-1436.
40. Soiffer, R., T. Lynch, M. Mihm, K. Jung, C. Rhuda, J. C. Schmollinger, F. S. Hodi, L. Liebster, P. Lam, S. Mentzer, S. Singer, K. K. Tanabe, A. B. Cosimi, R. Duda, A. Sober, A. Bhan, J. Daley, D. Neuberg, G. Parry, J. Rokovich, L. Richards, J. Drayer, A. Berns, S. Clift, L. K. Cohen, R. C. Mulligan, and G. Dranoff. 1998. Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA 95:13141-13146.
41. Solera, J., M. Rodriguez-Zapata, P. Geijo, J. Largo, J. Paulino, L. Saez, E. Martinez-Alfaro, L. Sanchez, M. A. Sepulveda, M. D. Ruiz-Ribo, et al. 1995. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob. Agents Chemother. 39:2061-2067.
42. Titball, R. W. 2008. Vaccines against intracellular bacterial pathogens. Drug Discov. Today 13:596-600.
43. Trampuz, A., K. E. Piper, J. M. Steckelberg, and R. Patel. 2006. Effect of gamma irradiation on viability and DNA of Staphylococcus epidermidis and Escherichia coli. J. Med. Microbiol. 55:1271-1275. (Pubitemid 44373165)
44. Vrioni, G., G. Pappas, E. Priavali, C. Gartzonika, and S. Levidiotou. 2008. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin. Infect. Dis. 46:e131-136.
45. Wyckoff, J. H., III, J. L. Howland, and A. W. Confer. 1993. Comparison of Brucella abortus antigen preparations for in vitro stimulation of immune bovine T-lymphocyte cell lines. Vet. Immunol. Immunopathol. 36:45-64.
46. Wyckoff, J. H., III, and R. D. Potts. 2007. Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis. Vet. Immunol. Immunopathol. 120:148-159.
47. Yingst, S., and D. L. Hoover. 2003. T-cell immunity to brucellosis. Crit. Rev. Microbiol. 29:313-331.
48. Zenewicz, L. A., K. E. Foulds, J. Jiang, X. Fan, and H. Shen. 2002. Nonsecreted bacterial proteins induce recall CD8 T-cell responses but do not serve as protective antigens. J. Immunol. 169:5805-5812.